View Clinical Trial (Medical Research Study)

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci - NCT00428844-54601(Clinical Trial 161349)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  La Crosse
State:  
WI
Zip Code: 54601
Conditions: Osteomyelitis
Purpose: This is a research study designed to look at the efficacy and safety of daptomycin given at a dose of 6 mg/kg or 8 mg/kg in subjects being treated for prosthetic hip or knee infections caused by Staphylococci. These types of bacteria are among the most common types of bacteria causing infections of prosthetic joints.
Study summary:
Criteria: Inclusion Criteria: - Subject must be between the ages of 18 and 80, inclusive - Subject must have a diagnosis of prosthetic joint infection (PJI) in a hip or knee joint which has never previously been totally revised because of an infection and for which they are anticipated to undergo a two-stage replacement surgery - Subject must have a Positive microbiological identifier of staphylococci. - If Subject is female of childbearing potential, must be willing to practice reliable birth control Exclusion Criteria: - Subject has permanent intravascular prosthetic material such as heart valves or pacemakers - Subject has a creatinine clearance (CLCR) <30 mL/min as determined by the Cockcroft-Gault equation using actual body weight. - Subject has significant hepatic dysfunction - Subject has a fungal or mycobacterial PJI - Subject is known to be HIV-infected with CD4 count ≤ 200 cells/ mm3 - Subject has an abnormal creatine phosphokinase (CPK) (elevated CPK level ≥ 2x ULN) at baseline as measured by central laboratory - Subject is currently under treatment with chemotherapeutic agents excluding chronic maintenance therapy (e.g. tamoxifen to prevent relapse of primary breast cancer) - Subject is pregnant, nursing, or lactating. - Subject is receiving or is expected to receive chronic immunosuppressive therapy during the study.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: April 13, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.